First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results
Jordana K Schmier1, David W Covert21Managing Scientist, Exponent Inc., Alexandria, VA, USA; 2Associate Director, Health Economics, Alcon Research Ltd., Ft. Worth, TX, USAObjective: To estimate first-year treatment costs among new initiators of topical prostaglandin analogs in a managed care populati...
محفوظ في:
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Dove Medical Press
2010-05-01
|
| سلاسل: | Clinical Ophthalmology |
| الوصول للمادة أونلاين: | http://www.dovepress.com/first-year-treatment-costs-among-new-initiators-of-topical--a4380 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|